Literature DB >> 18392335

Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.

Jérôme Duchemin1, Brigitte Pan-Petesch, Bertrand Arnaud, Marie-Thérèse Blouch, Jean-François Abgrall.   

Abstract

The thrombin generation test is used to study coagulation in patients with haemorrhagic diseases or with high thrombotic risk. To our knowledge, this is the first study investigating the relative influence of coagulation factors on thrombin generation in plasma. The aim was to investigate the influence of coagulant factors, anticoagulant factors, and tissue factor (TF) on three parameters: endogenous thrombin potential (ETP), peak thrombin concentration, and lag time for the appearance of thrombin. At a low TF concentration, all factors except factor XI influenced thrombin generation. At a high TF concentration, only the factors of the extrinsic pathway exerted an influence. ETP and peak thrombin were linearly correlated to factor II concentration. Factor V and factor VII effects increased hyperbolically with factor concentration. The influence of factor X on thrombin generation depended on TF concentration. In the absence of factor VIII and factor IX, ETP fell to 60-70% of the normal when peak thrombin fell to 25-30% of the normal. Fibrinogen concentration influenced ETP and peak thrombin and decreasing fibrinogen levels shortened the lag time. As expected, decreasing antithrombin concentration caused dramatic increases in thrombin generation. Protein S prolonged the lag time, especially at a low TF concentration. No effect of protein C was observed, likely due to the absence of thrombomodulin. The thrombin generation test was more sensitive to factor deficiencies at low than at high TF concentration. ETP was not the most critical parameter for studying coagulation factor deficiencies. Instead, peak thrombin was the most sensitive parameter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18392335     DOI: 10.1160/TH07-09-0581

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  27 in total

1.  Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins.

Authors:  Amy K L Chui; Tilini N Gunatillake; Vera Ignjatovic; Paul T Monagle; Padma Murthi; Shaun P Brennecke; John M Whitelock; Joanne M Said
Journal:  Blood Adv       Date:  2017-07-03

2.  Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.

Authors:  Kellie R Machlus; Emily A Colby; Jogin R Wu; Gary G Koch; Nigel S Key; Alisa S Wolberg
Journal:  Thromb Haemost       Date:  2009-11       Impact factor: 5.249

3.  Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.

Authors:  P L Lutsey; A R Folsom; S R Heckbert; M Cushman
Journal:  J Thromb Haemost       Date:  2009-07-28       Impact factor: 5.824

4.  Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay.

Authors:  Veronique Ollivier; Jianguo Wang; David Manly; Kellie R Machlus; Alisa S Wolberg; Martine Jandrot-Perrus; Nigel Mackman
Journal:  Thromb Res       Date:  2009-04-05       Impact factor: 3.944

5.  Response to Letter to the Editor submitted by Dr. Wada and Dr. Yamakawa re: Trauma-induced coagulopathy: The past, present, and future.

Authors:  Lucy Z Kornblith; Hunter B Moore; Mitchell J Cohen
Journal:  J Thromb Haemost       Date:  2019-09       Impact factor: 5.824

6.  Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro.

Authors:  Herm Jan M Brinkman; Frauke Swieringa; Marleen Zuurveld; Alicia Veninga; Sanne L N Brouns; Johan W M Heemskerk; Joost C M Meijers
Journal:  Res Pract Thromb Haemost       Date:  2022-04-25

7.  The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models.

Authors:  Abimbola A Onasoga-Jarvis; Karin Leiderman; Aaron L Fogelson; Michael Wang; Marilyn J Manco-Johnson; Jorge A Di Paola; Keith B Neeves
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

8.  Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study.

Authors:  Christof J Majoor; Marianne A van de Pol; Pieter Willem Kamphuisen; Joost C M Meijers; Richard Molenkamp; Katja C Wolthers; Tom van der Poll; Rienk Nieuwland; Sebastian L Johnston; Peter J Sterk; Elisabeth H D Bel; Rene Lutter; Koenraad F van der Sluijs
Journal:  Respir Res       Date:  2014-02-07

9.  Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy.

Authors:  C P D M de Breet; S Zwaveling; M J A Vries; R G van Oerle; Y M C Henskens; A W J Van't Hof; P E J van der Meijden; L Veenstra; H Ten Cate; R H Olie
Journal:  Front Cardiovasc Med       Date:  2021-06-10

10.  Global assays and the management of oral anticoagulation.

Authors:  Herm Jan M Brinkman
Journal:  Thromb J       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.